Intellectual Property and Biotechnology: The U.S. Internal Experience--Part II
, Continuing the discussion begun in the March 2006 issue of the Kennedy Institute of Ethics Journal, this paper further documents the failure of the United States to adequately consider possible modifications in the traditional robust system of intellectual property rights as applied to biotechnolo...
Main Author: | |
---|---|
Format: | Electronic Article |
Language: | English |
Check availability: | HBZ Gateway |
Journals Online & Print: | |
Fernleihe: | Fernleihe für die Fachinformationsdienste |
Published: |
Johns Hopkins Univ. Press
2006
|
In: |
Kennedy Institute of Ethics journal
Year: 2006, Volume: 16, Issue: 2, Pages: 105-128 |
Online Access: |
Volltext (lizenzpflichtig) Volltext (lizenzpflichtig) |
Summary: | , Continuing the discussion begun in the March 2006 issue of the Kennedy Institute of Ethics Journal, this paper further documents the failure of the United States to adequately consider possible modifications in the traditional robust system of intellectual property rights as applied to biotechnology. It discusses concrete suggestions for alternative disclosure requirements, for exemptions for research tools, and for improved access to clinical advances. In each of these cases, the modifications might be more responsive to the full set of relevant values. |
---|---|
ISSN: | 1086-3249 |
Contains: | Enthalten in: Kennedy Institute of Ethics, Kennedy Institute of Ethics journal
|
Persistent identifiers: | DOI: 10.1353/ken.2006.0007 |